[Does immunoscintigraphy improve early diagnosis of metastatic or recurrent cancer?]
- PMID: 2685691
- DOI: 10.1159/000216679
[Does immunoscintigraphy improve early diagnosis of metastatic or recurrent cancer?]
Abstract
In 42 patients with suspicion of recurrent colorectal cancer results of conventional diagnostic methods were compared to those of immunoscintigraphy. In 69% of all cases the intraoperative findings of a second-look operation served for validation, in 31% the follow-up was controlled. Localization of recurrent tumors was successful in 83% using conventional methods versus 57% by immunoscintigraphy. This procedure disappointed especially by a low sensitivity (23%) and low predictive parameters (pos.: 33%; neg.: 37%) in regard to diagnosis of extrahepatic tumors compared to results of conventional methods (77%), 94% respectively 79%). The quote of false positive results was surprisingly high in immunoscintigraphy (n = 12), 83% of these especially in localization of extrahepatic tumors. Therefore, the validity of immunoscintigraphy as an additive diagnostic tool for early detection of recurrent colorectal cancer must be regarded critically.
Similar articles
-
The value of immunoscintigraphy for the operative retreatment of colorectal cancer. Limitations of a new diagnostic method.Cancer. 1989 Aug 15;64(4):830-3. doi: 10.1002/1097-0142(19890815)64:4<830::aid-cncr2820640412>3.0.co;2-p. Cancer. 1989. PMID: 2743277
-
Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences.Eur J Surg Oncol. 1990 Aug;16(4):312-8. Eur J Surg Oncol. 1990. PMID: 2199223
-
Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?Q J Nucl Med. 2003 Jun;47(2):109-15. Q J Nucl Med. 2003. PMID: 12865871 Clinical Trial.
-
[Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist].Z Gastroenterol. 1990 Dec;28(12):673-7. Z Gastroenterol. 1990. PMID: 2087823 Review. German.
-
Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.Nucl Med Commun. 1999 Aug;20(8):689-96. doi: 10.1097/00006231-199908000-00002. Nucl Med Commun. 1999. PMID: 10451876 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical